Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism TIM1 inhibitors(T-cell immunoglobulin mucin receptor 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | US | ![]() | 22 Apr 2024 |